Saturday, November 2, 2024
Home Tags MCN-02-Apr-2020

MCN-02-Apr-2020 Related News

Cannabis, neuropsychiatry and education with Dr Ilya Reznik

Cannabis, neuropsychiatry and education with Dr Ilya Reznik

Dr Ilya Reznik discusses the use of cannabinoid-based medicines for neuropsychiatric disorders and the barriers to prescribing CBD. Dr Ilya Reznik has published many original...
Tried and tested high quality CBD products, brought to you by Handpicked CBD

Tried and tested high quality CBD products, brought to you by Handpicked CBD

Handpicked CBD is the UK’s choice online retail destination for buying tried and tested, high quality CBD products. The Handpicked CBD team is on a...
European Industrial Hemp Organisation: industrial hemp in Europe

European Industrial Hemp Association: industrial hemp in Europe

European Industrial Hemp Association Managing Director Lorenza Romanese details the current status of Europe’s hemp industry. The European Industrial Hemp Association (EIHA), based in both Brussels...
Legislation and regulation in US cannabis

Legislation and regulation in US cannabis

US Cannabis CEO Michael Patterson discusses federal and state cannabis laws and future policy developments. Michael Patterson is the CEO and founder of US Cannabis...
Liquid Health Labs and PowerCap® provide solutions for cannabis dosing

Liquid Health Labs and PowerCap® provide solutions for cannabis dosing

Dosing is the cannabis industry’s biggest problem. Amid the boom in legalised cannabis and associated products, dosing is proving to be the biggest challenge...
Wholly Hemp: putting phytocannabinoids in focus

Wholly Hemp: putting phytocannabinoids in focus

Wholly Hemp INC/Cannabidiol Life Brands, showcases the history and future of phytocannabinoid research in the USA and worldwide. In this article Jessica Arent, Chief Compliance...
Regulation and reputation with Medicinal Cannabis Industry Australia

Regulation and reputation with Medicinal Cannabis Industry Australia

Rosemary Richards of Medicinal Cannabis Industry Australia tells MCN about industry regulation, licensing and the future of Australian cannabis. Medicinal Cannabis Industry Australia (MCIA), the...
Medical Cannabis Network Quarterly Issue 2

Medical Cannabis Network Quarterly Issue 2

Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our second edition, which looks at cannabis research, policy and innovation around the world. Welcome to the...
Marijuana Policy Project: state level policy reform, what’s next?

Marijuana Policy Project: state level policy reform, what’s next?

Marijuana Policy Project Communications Manager Violet Cavendish explores the growing push for adult use legalisation in Arizona. The Marijuana Policy Project (MPP) is the nation’s...
urban-gro: cannabis cultivation space programming

urban-gro: cannabis cultivation space programming

urban-gro, Inc’s team of expert engineers and designers have developed an innovative process for cultivation space design. In this article, urban-gro, Inc explains more about...
Adivina and tissue culture: the power of predictability

Adivina and tissue culture: the power of predictability

Adivina is dedicated to bringing the proven cultivation benefits of tissue culture propagation to both the cannabis and hemp industries. Adivina Biosciences was founded by...
Exploring cannabinoid bioavailability in the medical cannabis industry

Exploring cannabinoid bioavailability in the medical cannabis industry

When medication is consumed it must reach the intended site of action, but what is the degree and rate at which it is absorbed...
Currency UK: helping cannabis businesses with international payments

Currency UK: helping cannabis businesses with international payments

Currency UK specialises in the movement of money internationally for cannabis businesses, and offers competitive exchange rates with zero fees. Currency UK specialises in the...
CBD: improving the odds of bone marrow transplant patients against GvHD

Kalytera Therapeutics: improving bone marrow transplants with CBD

Dr Sari Prutchi Sagiv, CSO at Kalytera Therapeutics Inc., showcases the potential of CBD to revolutionise treatment of Graft versus Host Disease. The development of...
Cosaint Nectar: unleashing the power of CBDA

Cosaint Nectar: unleashing the power of CBDA

Cosaint Nectar CEO Philip Tarazi details the unique benefits of CBDA and how Cosaint’s industry leading innovation can support pain management. If you have not...
CanPharma: bridging the gap between plant and patients

CanPharma: bridging the gap between plant and patients

With a team of medical experts and seasoned pharmaceutical entrepreneurs, CanPharma is set to drive innovation and to set new standards for optimal treatment...
CBD Export Global: streamlining global cannabis

CBD Export Global: streamlining global cannabis

CBD Export Global sets the international standard in sourcing, processing and supplying compliant hemp and cannabis ingredients for manufacturing consumer packaged goods. CBD Export Global...
Arge Canna: medical cannabis lobbying and patient advocacy in Austria

Arge Canna: medical cannabis lobbying and patient advocacy in Austria

Mag. Klaus Hübner of patient advocacy body Arge Canna tells MCN about Austria’s medical cannabis legislation and Arge Canna’s campaigns. Arge Canna is the primary...
Spektrum Cannabis Technologies: making the complex simple

Spektrum Cannabis Technologies: making the complex simple

Spektrum Technologies eliminates the need for new facility construction and building retrofitting by housing large scale extraction equipment in transportable, regulatory compliant units. Spektrum Cannabis...
Root Sciences: nanoemulsification and the beverage revolution

Root Sciences: nanoemulsification and the beverage revolution

By adding nanoemulsion systems to its line of hemp and cannabis processing equipment, Root Sciences is (yet again) changing the industry’s approach to producing...

Pin It on Pinterest